Godrej Agrovet IC Jan18
Godrej Agrovet IC Jan18
Godrej Agrovet IC Jan18
580
560
Well diversified business model: GAVL operates in four major segments: Animal
540 feed, agri chemicals, palm oil plantations and dairy. It also has presence in animal
520 feed business in Bangladesh and poultry meat products in India. This helps the
500 company maintain healthy growth rates as well as profitability even if one segment
Oct-17
Nov-17
Dec-17
Jan-18
is under pressure.
Major Player in unorganised industries: GAVL largely operates in segments
where the organised competitive pressure is relatively lower. The share of
organised market is less than 40% in segments such as cattle feed, dairy and palm
oil plantations. We reckon there are multiple smaller players in poultry feed and crop
protection chemicals; with demonetisation and GST roll-out, we expect unorganised
players to lose market shares to organised players like GAVL.
Initiate with BUY: We expect the company to report PAT CAGR of 20.6% over
FY17-20 and stable return ratios. We value the stock on a DCF basis to arrive at a
target price of Rs723. Assumptions include cost of equity at 11.8% and terminal
growth rate of 5%. At our target price of Rs723 and FY20E EPS of Rs21.0, the
stock trades at PE of 34x.
Market Cap Rs120bn/US$1.9bn Year to Mar FY17 FY18E FY19E FY20E
Reuters/Bloomberg GODE.BO / GOAGRO IN Revenue (Rs mn) 49,111 52,155 59,505 67,916
Shares Outstanding (mn) 192.0 Net Profit (Rs mn) 2,291 2,421 3,366 4,017
52-week Range (Rs) 624/529 Dil. Rec. EPS (Rs) 12.4 12.6 17.6 21.0
Free Float (%) 31.2 % Chg YoY 35.4 2.1 39.0 19.3
FII (%) 16.0 P/E (x) 50.4 49.4 35.5 29.8
Research Analysts: Daily Volume (US$'000) NA CEPS (Rs) 16.4 17.1 22.6 26.5
Absolute Return 3m (%) NA EV/EBITDA (x) 28.4 30.2 23.6 20.6
Aniruddha Joshi Absolute Return 12m (%) NA 0.7 0.8 1.0 1.0
Aniruddha.joshi@icicisecurities.com Dividend Yield (%)
+91 22 6637 7249 Sensex Return 3m (%) 7.6 RoCE (%) 15.7 15.8 20.4 21.8
Sensex Return 12m (%) 29.6 RoE (%) 23.8 17.4 19.5 20.4
Please refer to important disclosures at the end of this report
Godrej Agrovet, January 16, 2018 ICICI Securities
TABLE OF CONTENT
2
Godrej Agrovet, January 16, 2018 ICICI Securities
(?) Multibaggers
(Godrej Agrovet)
RoE
WACC(~13%)
Source: Company data, I-Sec research
3
Godrej Agrovet, January 16, 2018 ICICI Securities
Godrej Agrovet
Key segments of the company: The company is focused on multiple ‘agri input
segments’ such as animal feed and crop protection. It also focusses on multiple ‘agri
output’ segments such as palm oil, dairy and organised chicken products.
Animal feed – Engaged in business of animal feed required for poultry, cattle and
fish
Crop protection – Crop protection chemicals such as fungicides, insecticides,
herbicides, organic manures and plant growth regulators
Palm oil plantations – Plantations and refining of palm oil
Dairy – Milk and value added dairy products
Animal feed Vegetable oil Crop protection Dairy Others Animal feed Vegetable oil Crop protection Dairy Others
120% 110%
100%
100% 90%
80%
80% 70%
60%
60%
50%
40% 40%
30%
20% 20%
10%
0% 0%
FY13 FY14 FY15 FY16 FY17 FY13 FY14 FY15 FY16 FY17
Source: Company data, I-Sec research
4
Godrej Agrovet, January 16, 2018 ICICI Securities
5
Godrej Agrovet, January 16, 2018 ICICI Securities
Established distribution network
The company has developed a strong distribution network across segments.
Considering the company operates in rural areas, establishing distribution is more
difficult than urban markets. With established distribution network, we expect the
company to enjoy access to large customer base and it will be able to roll out multiple
new products at faster pace than peers. It can also leverage the distribution network of
one segment to drive revenues of other segments.
Chart 5: Established distribution network across segments
120,000
100,000
80,000
(No fo outlets)
60,000
40,000
20,000
0
Dairy Animal feed Crop protection
Source: Company data, I-Sec research
6
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 6: Presence in several unorganised markets
Organised Unorganised
120
100
80
60
40
20
0
Broiler Layer feed Cattle feed Fish feed Shrimp Crop Poultry Dairy
feed feed protection meat
Source: Company data, I-Sec research
Table 3: EBIT margins in low single digits reduce pricing threats by peers
Particulars FY13 FY14 FY15 FY16 FY17
Animal Feed 6.3 7.2 8.3 7.2 6.3
Dairy* 3.7
Godrej Agrovet 6.3 6.9 8.1 6.5 7.4
Source: Company data, I-Sec research *Dairy business consolidated from FY16
7
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 7: Animal feed: Global Chart 8: Animal feed: Indian Chart 9: Animal feed: Godrej
industry industry Agrovet
Other Other Shrimp &
feed feed Fish
Aqua feed 0%
Aqua feed 5% 12% 15%
4%
Cattle
feed Cattle
Poultry feed
20% feed 21% Poultry
45% 49%
Poultry feed
(15%) (85%)
Layer Broiler
8
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 11: Breakup of poultry feed industry in India (As per players)
(80-85%) (15-20%)
Organised Unorganised
players players
(70-75%) (10-15%)
3.0
(kg/person/year)
2.5
2.0
1.5
1.0
0.5
-
2000 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Source: Company data, I-Sec research
9
Godrej Agrovet, January 16, 2018 ICICI Securities
Expect steady growth of 10%+ in coming years
We expect the organised poultry feed industry to grow at more than 10% per annum in
coming years due to 1) higher penetration of organised animal feed, 2) growth in
poultry animals at CAGR of ~1%, and 3) inflation in animal feed prices.
800
700
600
500
(Rs bn)
400
300
200
100
0
FY17 FY20
Source: Company data, I-Sec research
10
Godrej Agrovet, January 16, 2018 ICICI Securities
Cattle feed in India
The cattle feed market in India is largely unorganised with share of organised market
at just 12%. Out of the organised feed industry, 70% of animal feed is sold by co-
operatives and private dairy players. Only 30% of organised cattle feed is sold by
independent animal feed manufacturers such as Godrej Agrovet.
Chart 14: Breakup of cattle feed industry in India
Private
playes
30%
Unorganised Organised
88% 12%
Co-
operatives
70%
10,000
8,000
6,000
4,000
2,000
0
USA
Finland
India
Saudi Arabia
Sweden
Japan
Denmark
Israel
Canada
Spain
World average
11
Godrej Agrovet, January 16, 2018 ICICI Securities
Benefits to farmers from higher productivity
The farmers benefit from higher productivity of animals in terms of 1) higher milk yield
per bovine, 2) higher number of calves in a lifetime of bovine, and 3) convenience.
5
4
3
2
1
0
FY14 FY17 FY20P
Source: Company data, I-Sec research
12
Godrej Agrovet, January 16, 2018 ICICI Securities
Aqua feed in India
The aqua feed market has 2 segments: Fish and shrimp feed. Fish feed accounts for
25% of the industry and shrimp feed accounts for 75%. Organised players account for
50% share of fish feed market whereas organised players account for 80% of shrimp
feed market.
Aqua feed
(25%) (75%)
Domestic Exports
1200
1000
800
(Rs bn)
600
400
200
0
FY11 FY12 FY13 FY14 FY15 FY16
13
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 19: Steady growth of fish feed market Chart 20: Growing shrimp feed market in India
30 120
25 100
20 80
(Rs bn)
(Rs bn)
15 60
10 40
5 20
0 0
FY13 FY17 FY20P FY13 FY17 FY20P
Source: Company data, I-Sec research
0
(%)
(5)
(10)
(15)
FY14 FY15 FY16 FY17 FY18E
Source: Company data, I-Sec research
14
Godrej Agrovet, January 16, 2018 ICICI Securities
Wages are growing at faster than inflation in maize
The farmer has 2 choices in case of animal feed: 1) Procure animal feed from animal
feed companies, or 2) hire labour to prepare the animal feed. We note that maize is a
key raw material for animal feed and inflation in maize prices is less than increase in
agri wages. Hence, it is cost effective for the farmer to procure the ready meal instead
of incurring higher labour charges.
Chart 22: Rural wages growth rising at faster pace than maize inflation
WPI: Maize Rural wages
450
400
350
300
250
200
150
100
50
0
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Source: Company data, I-Sec research (Rebased to 100) maize is a key RM for animal feed
Realizing the changing dynamics of the animal feed industry, GAVL has entered the
dairy and poultry business. Growth of Creamline as well as Godrej Tyson will create
captive market for Godrej Agrovet.
Animal feed
Milk
Source: Company data, I-Sec research
15
Godrej Agrovet, January 16, 2018 ICICI Securities
9%
8%
7%
6%
5%
4%
3%
2%
1%
0%
FY13 FY14 FY15 FY16 FY17
Source: Company data, I-Sec research
Sub-segmentation strategy
Instead of launching just one product, the company has introduced multiple products
targeted at diverse needs of the animals. In case of cattle feed, it has introduced
different feed for calf, lactating cow, and feed for improving productivity. It has also
rolled out feed mix for adding to different types of feeds. Similarly, it has introduced a
portfolio of products across needs of poultry and fish and shrimp.
16
Godrej Agrovet, January 16, 2018 ICICI Securities
We note this strategy allows the company to target consumers across needs. Apart
from differentiated products, Godrej Agrovet has introduced multiples SKUs at
different price points.
Godrej Agrovet
To improve milk
productivity
Milk More
Feed mix
Moo Magicmix
17
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 26: Land under cultivation in India growing at meager rate of 0.1% p.a.
135
130
125
(mn Hectares)
120
115
110
105
FY67
FY69
FY71
FY73
FY75
FY77
FY79
FY81
FY83
FY85
FY87
FY89
FY91
FY93
FY95
FY97
FY99
FY01
FY03
FY05
FY07
FY09
FY11
FY13
FY15
Source: Company data, I-Sec research
16
14
12
(kg/hectare)
10
0
Taiwan China Japan USA France UK India
Source: Company data, I-Sec research
18
Godrej Agrovet, January 16, 2018 ICICI Securities
Benefits to farmers by using agri inputs
Usage of crop protection chemicals results in higher farm produce. For every rupee
invested in crop protection chemicals, the farmer generates Rs2+ depending on the
crop. We reckon this indicates strong growth potential of the agri inputs segment.
Chart 28: Benefits to farmers by usage of Crop Table 9: Losses that can be avoided with use of
protection chemicals Crop protection chemicals
10% Loss Cost of Agrochemicals Crop Avoidable losses (%) Cost: benefit ratio
Cotton 49-90 1:07
25,000
Rice 21-51 1:07
Chart 29: Global consumption of herbicides, insecticides and fungicides vis-à-vis that in India
Herbicides
45%
Insecticides Insecticides
25% 54%
Source: Company data, I-Sec research
19
Godrej Agrovet, January 16, 2018 ICICI Securities
Growing crop protection industry in India
With rising usage of pesticides, the industry has clocked CAGR of 9% over FY13 to
FY17. The herbicides and fungicides segments are expected to drive growth in the
industry. Lower share of cotton insecticides will result in lower growth of insecticides
industry.
250
Domestic crop protection industry
200
150
(Rs bn)
100
50
0
FY13 FY14 FY15 FY16 FY17 FY18P FY19E FY20E
Source: Company data, I-Sec research
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
FY13 FY14 FY15 FY16 FY17
Source: Company data, I-Sec research
20
Godrej Agrovet, January 16, 2018 ICICI Securities
Distribution a key growth driver for Godrej Agrovet
The distribution network plays a key role in agro chemicals. There are ~100,000 retail
outlets in India selling agro chemicals. Godrej distributes through ~25,000 retail
outlets. Steady growth in distribution can also drive the growth of Godrej Agrovet.
We also note the company’s sales per outlet is comparable with other crop protection
companies.
Chart 32: Strong scope to expand no. of outlets Chart 33: Comparable sales per outlet for peers#
(Sales/Outlet - Rs)
50,000
120,000
40,000
100,000
30,000
20,000 80,000
10,000 60,000
0 40,000
Dhanuka
Insecticides
PI
Godrej
20,000
-
PI Godrej Insecticide Dhanuka
Source: Company data, I-Sec research * Outlets of Insecticides India #Considered only domestic revenues
Table 11: Key financials of Astec Chart 34: Growth of exports market
Particulars FY13 FY14 FY15 FY16 FY17
160
Net sales 1,748 2,070 2,669 2,330 2,987
140
EBITDA 270 348 372 284 523
120
Export market (Rsbn)
21
Godrej Agrovet, January 16, 2018 ICICI Securities
Product portfolio of the company
The company is present in all 5 segments of agri chemicals. It sells multiple generic
products. Major brands of the company include Double, Vipul, Combine and Hitweed.
Godrej Agrovet has also introduced 6 new products in past 3 years. It recently
introduced Oryzostar brand (bispyribac sodium) which can take market share from the
market leader Nominee Gold of PI Inds.
22
Godrej Agrovet, January 16, 2018 ICICI Securities
Comparison with other Crop protection companies
Table 14: Comparison with key Crop protection players
FY13 FY14 FY15 FY16 FY17
EBIT margin (%)
Godrej# 22.5 21.4 25.1 19.1 22.1
PI 12.9 14.7 15.5 18.1 21.2
Dhanuka 13.3 15.7 16.0 16.2 17.6
Insecticides 10.3 8.7 10.0 7.6 8.9
RoCE (%)
Godrej 57.9 82.7 55.6 30.1 33.9
PI 23.8 32.4 34.8 31.8 30.7
Dhanuka 26.5 33.2 30.2 28.0 28.9
Insecticides 16.2 15.6 16.8 11.9 14.3
23
Godrej Agrovet, January 16, 2018 ICICI Securities
1,200,000
1,000,000
800,000
(te)
600,000
400,000
200,000
0
FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16
Source: Company data, I-Sec research
24
Godrej Agrovet, January 16, 2018 ICICI Securities
Target area in India for palm oil plantations
Palm oil gives oil yield of 4-6 tonnes per hectare to the farmers, higher than any other
type of oil. Palm oil being a major source of consumption (edible oil), raw material for
soaps as well as fuel ensures healthy demand prospects. Thus, the cultivation of palm
oil trees is expected to grow at steady pace in India. The major production area for
palm oil plantation is Andhra Pradesh. However, there is potential to grow palm oil
trees in other parts of India as follows.
300,000
250,000
200,000
150,000
100,000
50,000
0
Orissa
Kerala
Tamil Nadu
Andhra Pradesh
Arunachal Pradesh
Assam
Chattisgarh
Goa
Karnataka
Tripura
Gujarat
Maharashtra
Meghalaya
Mizoram
Bihar
Nagaland
West Bengal
Source: Company data, I-Sec research
Chart 37: Market shares of key players in palm oil business in India
Others
16%
Godrej Agrovet
35%
3F
8%
Ruchi Soya
30%
Source: Company data, I-Sec research
25
Godrej Agrovet, January 16, 2018 ICICI Securities
Hectares under cultivation for Godrej Agrovet
Godrej Agrovet has 61,700 hectares under cultivation for palm oil at the end of FY17.
This number has increased from 30,000 hectares in FY09, clocking CAGR of 9.3%
over FY09-17. The company wants to steadily expand the area under cultivation of
palm oil going forward at a CAGR of 5-6%.
60,000
50,000
(Hecatres)
40,000
30,000
20,000
10,000
0
FY09 FY10 FY11 FY13 FY16 FY17
Table 16: Steady growth in yield per hectare with maturity of trees
Tree age Hectares %
0-3 20,005 30
3-8 21,349 25
8-25 20,346 45
Total 61,700 100
Source: Company data, I-Sec research
26
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 39: Palm oil prices have major bearing on EBIT margin
60
50
40
30
20
10
0
FY13 FY14 FY15 FY16 FY17 FY18E
Source: Company data, I-Sec research
We reckon the understanding of palm oil offers GAVL strong competitive advantage
over other players.
27
Godrej Agrovet, January 16, 2018 ICICI Securities
Dairy segment
Growing bovine population and productivity of bovines
The bovine population has grown at CAGR of 1.2% per annum over 1951-2012.
However, the growth slowed to 0.1% CAGR over 1997-2012. Though India has one of
the largest populations of bovines as well as highest milk production in the world, the
milk production per bovine is one of the lowest in the world.
Chart 40: Growing bovine population in India Chart 41: Rising milk production per bovine
1.2
140
120 1.0
100
0.8
(Per te/Bovine)
(Mn)
80
0.6
60
40 0.4
20
0.2
0
1956
1961
1966
1972
1977
1982
1987
1992
1997
2003
2007
2012
0.0
FY92 FY97 FY03 FY07 FY12
Source: Company, I-Sec research
Chart 42: Growing milk production in India… Chart 43: …and rising per capita availability
180 400
160 350
140 300
120
250
(GMS/day)
(mn te)
100
200
80
150
60
40 100
20 50
0 0
FY92
FY94
FY96
FY98
FY00
FY02
FY04
FY06
FY08
FY10
FY12
FY14
FY16
FY92
FY94
FY96
FY98
FY00
FY02
FY04
FY06
FY08
FY10
FY12
FY14
FY16
28
Godrej Agrovet, January 16, 2018 ICICI Securities
Co-operatives dominate the milk collection & distribution in India
Out of total production of milk, 54% of milk in India is consumed by farmers and their
families. The rest of the milk is sold to consumers/institutions. Out of the marketable
milk, 30% is sold directly to consumers by local milkmen. Only 70% of marketable milk
is purchased either by the private players and/or co-operatives.
Milk Consumption
Organised Unorganised
(70%) (30%)
We believe there is limited scope for any penetration-led growth for dairy companies
as entire population consumes milk in some format. However, the growth opportunity
can generate from:
29
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 45:Per capita consumption of milk remains Chart 46: Cost of consumption of milk is lower
lower in India than nominal GDP growth
300 500 Cost of consumption of milk Nominal GDP
450
250
400
350
200
Average 300
(Ltrs/yr)
150 250
200
100 150
100
50
50
0
0
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
USA Europe Russia Brazil India China
Fed
Source: Company, I-Sec research
Chart 47:CAGR in milk production of major Chart 48: Rising share of India in global milk
economies production
Finland
New Zealand
Pakistan
Romania
Russia
Sri Lanka
Swizertland
Thailand
United Kingdom
USA
Brazil
Germany
Norway
South Africa
Mauritiania
Afganistan
Bangladesh
Chile
China
Indonesia
Mexico
Ireland
Sweden
Vietnam
Denmark
Nepal
Netherlands
Argentina
Australia
Canada
France
4%
2%
0%
1970 1975 1980 1985 1990 1995 2000 2005 2010 2013
30
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 49: Private players have smaller share of the Chart 50: Rising share of organised players
milk distribution
Direct milk procurement of milk from farmers as selling prices are capped by co-
operatives.
Right product mix to reduce investments in working capital and fixed assets, and
expand return ratios.
Branding of the products to introduce extensions, drive premiumisation and enjoy
better realisations.
Distribution expansion for all types of products such as frozen, chilled, shelf stable
and fresh milk, and
Large number of manufacturing units since milk products can be distributed within
a limited reach in a region due to its perishable nature.
31
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 51: Geographical revenue breakup of the company
Maharashtra
Kerala
3%
1%
Tamil Nadu
23%
Telangana
40%
Andhra Pradesh
Karnataka 27%
6%
Source: Company, I-Sec research
Focus on ‘high RoE’ segment: The Company has strong focus on generating high
return on investments. It primarily sells milk and fresh milk products which enjoy higher
margins and lower investments in working capital. We reckon the company does not
intend to enter segments such as cheese which have low return ratios.
Ice cream
1%
Ghee & Butter
12%
Fresh milk
products
17%
Milk
70%
Healthy scope to grow in Andhra Pradesh: We believe for any organised player, it
is easier to grow at more than 10% considering growth in market as well as shift from
unorganised to organised. We also note the milk production growth in key market of
Creamline i.e. Andhra Pradesh is upwards of 7% over past 10 years.
32
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 53: Milk production in Andhra Pradesh* clocking 7% CAGR
18,000 Andhra Pradesh
16,000
14,000
12,000
10,000
8,000
6,000
4,000
2,000
0 FY02
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
Source: Company, I-Sec research *includes Andhra Pradesh & Telangana
6% 50%
5%
40%
4%
30%
3%
20%
2%
1% 10%
0% 0%
Heritage Prabhat Hatsun Godrej Parag Heritage Hatsun Prabhat Godrej Parag
Source: Company, I-Sec research
EBIT margins to improve ahead: The drought in South India resulted in higher milk
prices over past 2 years and most of the milk companies were not able to pass on the
entire increase in raw material prices to end consumers. This resulted in low
profitability margins for most of the dairy companies. We expect the situation to
improve going forward and note the milk prices have already corrected by 7-8% now
from peak prices in May-June 2017. Thus we expect all dairy companies including
Creamline to enjoy steady improvement in margins over next 2 years.
33
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 56: EBIT margins of dairy companies were lower in FY17 than average*
FY17 Average
8
(%)
4
0
Godrej Hatsun Heritage Parag Prabhat
Source: Company, I-Sec research *Average EBIT margin over FY13-17
34
Godrej Agrovet, January 16, 2018 ICICI Securities
Other businesses
Besides the above mentioned four segments, Godrej Agrovet has two major business
investments as
1) ACI Godrej Bangladesh – animal feed company in Bangladesh, and
2) Godrej Tyson – company focused on selling poultry meat and value-added poultry
meat Products Company in India.
Table 19: Key details of Joint ventures and associates
Godrej
Agrovet Revenues*
Associates/JV Partner stake (%) Business (Rsmn)
ACI Godrej Bangladesh ACI 50% Animal feed in Bangladesh 6,040
Godrej Tyson Tyson Inc 49% Chicken & value-added meat products 4,459
Source: Company data, I-Sec research *Stake of Godrej Agrovet (FY17)
3,000
2,500
(Rs mn)
2,000
1,500
1,000
500
0
FY15 FY16 FY17
Source: Company data, I-Sec research *GAVL share
Godrej Tyson
Godrej Agrovet and Tysons Foods, USA have a 49:51 JV for producing and selling
poultry meat and value-added products of poultry meet. The major brands of this
company are Real Good chicken, Tyson and Yummiez.
35
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 58: Revenue and growth rates of Godrej Tyson*
2,250
2,200
2,150
2,100
2,050
(Rs mn)
2,000
1,950
1,900
1,850
1,800
1,750
FY15 FY16 FY17
Source: Company data, I-Sec research *GAVL share
Chart 59: Lower meat consumption in India Chart 60: Unorganised players have 30% share
18
16
14 Unorganised
30%
12
10
(kg)
4
Organised
2 70%
0
India World
Source: Company data, I-Sec research
36
Godrej Agrovet, January 16, 2018 ICICI Securities
Improving affordability of meat products
The WPI index points that the prices of food products are growing at a faster rate
compared to egg, meat and fish prices over the past 6 years. If prices of major protein-
rich pulses and other food products rise at higher rate than meat, it may result in some
consumers shifting to cheaper non-vegetarian protein foods.
150
140
130
120
110
100
90
Jun-12
Aug-12
Dec-12
Jun-13
Aug-13
Dec-13
Jun-14
Aug-14
Dec-14
Jun-15
Aug-15
Dec-15
Jun-16
Aug-16
Dec-16
Jun-17
Aug-17
Feb-12
Apr-12
Oct-12
Feb-13
Apr-13
Oct-13
Feb-14
Apr-14
Oct-14
Feb-15
Apr-15
Oct-15
Feb-16
Apr-16
Oct-16
Feb-17
Apr-17
Oct-17
Source: Company data, I-Sec research *WPI rebased to 100
37
Godrej Agrovet, January 16, 2018 ICICI Securities
Financial performance
Expect revenue CAGR of 11.4% over FY17-FY20
GAVL has reported healthy revenue CAGR of 15.5% over FY13-FY17 on the back of
new product launches and acquisition of Astec and Creamline. Segment-wise CAGR
over FY13-17 are as follows: Animal feed 4%, crop protection 36.3%, palm oil 16.5%.
Dairy segment was consolidated FY16 onwards. The company’s revenue is expected
to clock CAGR of 11.4% over FY17-20.
80,000 35
70,000 30
60,000
25
50,000
(Rs mn)
20
40,000
15
30,000
10
20,000
10,000 5
0 0
FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E
Source: Company data, I-Sec research
7,000 10
9
6,000
8
5,000 7
(Rs mn)
4,000 6
5
3,000 4
2,000 3
2
1,000
1
0 0
FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E
Source: Company data, I-Sec research
38
Godrej Agrovet, January 16, 2018 ICICI Securities
Expect net profit to clock 20.6% CAGR
With reducing interest cost after repayment of debt post IPO and healthy operating
performance, we expect net profit to clock CAGR of 20.6% over FY17-20. We expect
the company’s effective income tax rate to be 30%.
Chart 64: Net profit CAGR of 20.6% over FY17-20 Chart 65: Net profit margin to improve
(%)
(Rs mn)
2,500
30 3
2,000
20
1,500 2
1,000 10
0 1
500
0 (10) 0
FY13
FY14
FY15
FY16
FY17
FY18E
FY19E
FY20E
FY13
FY14
FY15
FY16
FY17
FY18E
FY19E
FY20E
Source: Company data, I-Sec research
RoE RoCE
40.0
35.0
30.0
25.0
(%)
20.0
15.0
10.0
5.0
0.0
FY14 FY15 FY16 FY17 FY18E FY19E FY20E
Source: Company data, I-Sec research
39
Godrej Agrovet, January 16, 2018 ICICI Securities
Working capital analysis
Though the working capital days are generally higher in agri industry, we note the
company has been able to reduce the net working capital days from FY16 to FY17.
We expect some improvement in working capital days going forward due to improving
agri growth prospects and brand power.
Net WC days
80
70
60
50
(days)
40
30
20
10
0
FY13
FY14
FY15
FY16
FY17
FY18E
FY19E
FY20E
Source: Company data, I-Sec research
FCF generation
The acquisition of Astec and Creamline resulted in negative FCF generation in FY16.
However, with limited capex and net cash balance sheet, we expect FCF generation to
remain strong.
Chart 68: Operating cash flow to EBITDA Chart 69: Free cash flow to PAT
OCF/EBITDA FCF/PAT
400
200
300
150 200
100
100
(%)
(%)
50 (100)
(200)
0
(300)
FY13
FY14
FY15
FY16
FY17
FY18E
FY19E
FY20E
(50)
FY13 FY14 FY15 FY16 FY17 FY18EFY19EFY20E
Source: Company data, I-Sec research
40
Godrej Agrovet, January 16, 2018 ICICI Securities
Key assumptions
Table 20: Key assumptions
(Rs mn)
FY16 FY17 FY18E FY19E FY20E
Segmental revenues
Animal feed 25,442 26,208 26,520 30,214 34,432
Agri inputs 4,959 7,647 8,412 9,719 11,237
Palm oil plantations 4,042 5,066 5,725 6,584 7,571
Dairy 2,729 10,099 11,235 12,700 14,358
Others 377 243 262 289 318
Net Revenues 37,502 49,111 52,155 59,505 67,916
Growth (%) 13.2 31.0 6.2 14.1 14.1
Gross profit 8,050 11,149 11,474 13,686 15,621
Gross margin (%) 21.5 22.7 22.0 23.0 23.0
EBITDA 2,965 4,380 4,277 5,474 6,248
EBITDA margin (%) 7.9 8.9 8.2 9.2 9.2
PBT 2,092 3,339 3,547 4,906 5,846
PBT Margin (%) 5.6 6.8 6.8 8.2 8.6
Tax rate (%) 36.1 29.7 30.0 30.0 30.0
PAT 1,692 2,291 2,421 3,366 4,017
PAT Margin (%) 3.6 4.8 4.8 5.8 6.0
PAT Growth (%) (2.5) 35.4 5.7 39.0 19.3
Capex (1,223) (1,949) (1,500) (1,600) (1,600)
Net working capital days 72.2 21.6 17.6 14.9 14.1
Operating cash flow 350 8,259 3,671 4,414 4,870
Free cash flow (3,887) 6,310 2,171 2,814 3,270
OCF/EBITDA (%) 11.8 188.5 85.8 80.6 77.9
Source: Company data, I-Sec research
41
Godrej Agrovet, January 16, 2018 ICICI Securities
Valuation
We have valued Godrej Agrovet on DCF basis. Our DCF valuation indicates value per
share of Rs723. Implied PE multiple at our target price and FY20E EPS works out to
34x.
DCF-based valuation
Valuing Godrej Agrovet on the DCF methodology involves three stages.
Stage 1 (FY17-20): During this period, we expect the company to grow its
revenues and PAT at CAGRs of 11.4% and 20.6% respectively. We also expect
the RoCE to remain above 16% over FY17-20.
Stage 2 (FY20-30): During this period, we expect the company to post revenue
and PAT CAGRs of 15.8% and 19.7%, respectively till FY28.
Stage 3 (FY30 onwards): We assume a perpetual growth rate of 5%.
To arrive at the cost of equity of 11.8%, we have assumed risk free rate of 8% and
market rate of return at 14%. Based on these assumptions, we arrive at a valuation of
Rs723/share.
Key risks
Weaker than expected monsoon
Steep increase in competitive pressures
Increase in raw material prices
42
Godrej Agrovet, January 16, 2018 ICICI Securities
Management team
Godrej group owns 68.8% stake in the company and Adi Godrej, Nadir Godrej,
Jamshyd Godrej, Nisaba Godrej and Tanya Dubhash are the directors of the
company. The business is managed by a professional team led by Balram Yadav. S
Varadaraj is the CFO of the company. The company has inducted many senior
professional in various sales, product management, HR and finance roles to steer the
growth plans.
43
Godrej Agrovet, January 16, 2018 ICICI Securities
Financials
Table 23: Profit & Loss statement
(Rs mn, year ending March 31)
FY15 FY16 FY17 FY18E FY19E FY20E
Gross Sales 33,118 37,550 49,264 52,155 59,505 67,916
Less: Excise Duty - 48 153 - - -
Net Sales 33,118 37,502 49,111 52,155 59,505 67,916
Growth (%) 13.2 31.0 6.2 14.1 14.1
Expenditure
Cost of Goods Sold 26,157 29,451 37,961 40,681 45,819 52,295
Staff Cost 1,334 1,557 2,327 2,451 2,797 3,192
Power & Fuel 429 641 769 834 952 1,087
Carriage & Freight 67 253 273 313 357 407
Advt & Sales Promotion 387 622 758 782 893 1,019
Other Expenses 1,010 1,345 1,753 1,878 2,142 2,445
EBITDA 3,059 2,965 4,380 4,277 5,474 6,248
EBITDA margin (%) 9.2 7.9 8.9 8.2 9.2 9.2
Depreciation 370 524 747 861 964 1,055
EBIT 2,690 2,441 3,634 3,415 4,510 5,193
Interest Expense & Bank Exps 655 977 863 433 198 131
Other Income 137 627 569 565 593 783
Profit Before Tax 2,172 2,092 3,339 3,547 4,906 5,846
Income Taxes 605 754 991 1,064 1,472 1,754
Income tax rate (%) 27.9 36.1 29.7 30.0 30.0 30.0
Profit After Tax 1,566 1,337 2,348 2,483 3,434 4,092
Growth (%) (14.6) 75.6 5.8 38.3 19.2
Share of Profit From Associates 170 327 187 206 227 250
Pref. Dividends/Minority Interest - (29) 244 268 295 325
Profit Before X/O 1,736 1,692 2,291 2,421 3,366 4,017
Extraordinary Items 340 924 194 - - -
Profit for Shareholders 2,076 2,617 2,485 2,421 3,366 4,017
Source: Company data, I-Sec research
44
Godrej Agrovet, January 16, 2018 ICICI Securities
Table 25: Cash flow statement
(Rs mn, year ending March 31)
FY15 FY16 FY17 FY18E FY19E FY20E
OCF before W/C changes 2,018 1,374 3,114 3,282 4,330 5,072
W/c Changes (1,552) (1,024) 5,145 389 84 (202)
OCF After W/C Changes 466 350 8,259 3,671 4,414 4,870
Cash Flow from Investing - - - - - -
Capital Expenditure (1,113) (1,302) (2,049) (1,500) (1,600) (1,600)
Disposal 20 79 100 - - -
Investments (241) (134) 934 - - (2,000)
Acquisitions - (3,014) - - - -
Net Cash used in Investing (1,334) (4,371) (1,015) (1,500) (1,600) (3,600)
Cash Flow from Financing - - - - - -
Changes in Share Capital - 39 8 3,000 - -
Changes in Loans 686 4,713 (7,027) (4,000) (1,600) -
Dividends (826) (541) - (1,009) (1,121) (1,345)
Net Cash used in Financing (140) 4,210 (7,019) (2,009) (2,721) (1,345)
ExtraOrdinary Items - - - - - -
Changes in Cash & Equivalents (1,008) 189 224 162 93 (75)
Opening Cash & Equivalents 1,139 125 314 623 785 878
Closing Cash & Equivalents 130 314 538 785 878 803
Free Cash Flow (628) (3,887) 6,310 2,171 2,814 3,270
Source: Company data, I-Sec research
45
Godrej Agrovet, January 16, 2018 ICICI Securities
Table 26: Ratio analysis
(Rs mn, year ending March 31)
FY15 FY16 FY17 FY18E FY19E FY20E
Profitability Ratios
Gross margin 21.0 21.5 22.7 22.0 23.0 23.0
EBITDA Margin 9.2 7.9 8.9 8.2 9.2 9.2
EBIT Margin 8.1 6.5 7.4 6.5 7.6 7.6
PBT Margin 6.6 5.6 6.8 6.8 8.2 8.6
PAT Margin 4.7 3.6 4.8 4.8 5.8 6.0
Income Tax Rate 27.9 36.1 29.7 30.0 30.0 30.0
RoE 33.4 32.7 23.8 17.4 19.5 20.4
RoCE 20.9 12.6 15.7 15.8 20.4 21.8
Turnover Ratios
Debtors Turnover ratio 8.1 12.1 10.6 10.3 10.0 10.0
Current Liabilities Turnover Ratio 6.5 8.9 17.1 17.1 17.1 17.1
Inventory Turnover Ratio 11.7 17.8 15.0 14.5 14.3 14.3
Fixed Assets Turnover Ratio 20.6 32.6 27.0 26.7 24.5 22.2
Valuation Ratios
Price Earnings 66.6 68.3 50.4 49.4 35.5 29.8
Price/Book Value 16.9 12.6 9.9 7.4 6.5 5.7
EV/Sales 3.8 3.3 2.5 2.5 2.2 1.9
EV/EBITDA 40.7 42.0 28.4 30.2 23.6 20.6
Dividend Yield 4.1 0.7 0.7 0.8 1.0 1.0
Other Ratios
Net debt/Equity 0.9 1.6 0.8 0.3 0.2 0.1
FCF/EPS (40.1) (65.3) 268.7 87.4 81.9 79.9
OCF/Sales 1.4 0.9 16.8 7.0 7.4 7.2
Div Payout Ratio 275.8 48.5 36.4 39.6 34.2 28.6
Source: Company data, I-Sec research
46
Godrej Agrovet, January 16, 2018 ICICI Securities
Charts
Chart 1: RoE and growth dynamics ...................................................................................... 3
Chart 2: Godrej Agrovet’s business segments ..................................................................... 4
Chart 3: Revenue breakup of GAVL ..................................................................................... 4
Chart 4: EBIT breakup of GAVL ........................................................................................... 4
Chart 5: Established distribution network across segments ................................................. 6
Chart 6: Presence in several unorganised markets .............................................................. 7
Chart 7: Animal feed: Global industry ................................................................................... 8
Chart 8: Animal feed: Indian industry .................................................................................... 8
Chart 9: Animal feed: Godrej Agrovet ................................................................................... 8
Chart 10: Breakup of poultry feed industry in India .............................................................. 8
Chart 11: Breakup of poultry feed industry in India (As per players) .................................... 9
Chart 12: Rising per capita consumption of chicken in India ................................................ 9
Chart 13: Steady growth of poultry feed market in India .................................................... 10
Chart 14: Breakup of cattle feed industry in India ............................................................... 11
Chart 15: Low milk productivity of cows in India ................................................................. 11
Chart 16: Steady growth of cattle feed market in India ....................................................... 12
Chart 17: Breakup of aqua feed industry in India ............................................................... 13
Chart 18: Growth of seafood industry in India .................................................................... 13
Chart 19: Steady growth of fish feed market ...................................................................... 14
Chart 20: Growing shrimp feed market in India .................................................................. 14
Chart 21: Correlation in monsoon deficit and usage of animal feed ................................... 14
Chart 22: Rural wages growth rising at faster pace than maize inflation ........................... 15
Chart 23: How the value chain works in the industry? ........................................................ 15
Chart 24: EBIT margin of animal feed segment in mid-single digits ................................... 16
47
Godrej Agrovet, January 16, 2018 ICICI Securities
Chart 25: Sub-segmentation strategy of the company ....................................................... 17
Chart 26: Land under cultivation in India growing at meager rate of 0.1% p.a................... 18
Chart 27: Per hectare usage of Crop protection chemicals in India ................................... 18
Chart 28: Benefits to farmers by usage of Crop protection chemicals ............................... 19
Chart 29: Global consumption of herbicides, insecticides and fungicides vis-à-vis that in
India............................................................................................................................... 19
Chart 30: Growing crop protection industry in India ........................................................... 20
Chart 31: Segments of crop protection chemicals .............................................................. 20
Chart 32: Strong scope to expand no. of outlets ................................................................ 21
Chart 33: Comparable sales per outlet for peers# .............................................................. 21
Chart 34: Growth of exports market .................................................................................... 21
Chart 35: Production of oil palm fresh fruit bunches in India .............................................. 24
Chart 36: Target area for palm oil plantations in India ........................................................ 25
Chart 37: Market shares of key players in palm oil business in India ................................. 25
Chart 38: Hectares under cultivation for Godrej Agrovet .................................................... 26
Chart 39: Palm oil prices have major bearing on EBIT margin........................................... 27
Chart 40: Growing bovine population in India ..................................................................... 28
Chart 41: Rising milk production per bovine ....................................................................... 28
Chart 42: Growing milk production in India… ..................................................................... 28
Chart 43: …and rising per capita availability ...................................................................... 28
Chart 44: Co-operatives dominate the milk collection and distribution ............................... 29
Chart 45:Per capita consumption of milk remains lower in India ........................................ 30
Chart 46: Cost of consumption of milk is lower than nominal GDP growth ........................ 30
Chart 47:CAGR in milk production of major economies ..................................................... 30
Chart 48: Rising share of India in global milk production ................................................... 30
Chart 49: Private players have smaller share of the milk distribution ................................. 31
Chart 50: Rising share of organised players....................................................................... 31
Chart 51: Geographical revenue breakup of the company ................................................. 32
Chart 52: Product portfolio of Creamline dairy.................................................................... 32
Chart 53: Milk production in Andhra Pradesh* clocking 7% CAGR .................................... 33
Chart 54:EBIT margins of peers ......................................................................................... 33
Chart 55: Return ratios of peers.......................................................................................... 33
Chart 56: EBIT margins of dairy companies were lower in FY17 than average* ............... 34
Chart 57: Revenues and growth rates of ACI Bangladesh* ............................................... 35
Chart 58: Revenue and growth rates of Godrej Tyson* ...................................................... 36
Chart 59: Lower meat consumption in India ....................................................................... 36
Chart 60: Unorganised players have 30% share ................................................................ 36
Chart 61: Lower inflation improving affordability of meat products ..................................... 37
Chart 62: Healthy revenue growth ahead ........................................................................... 38
Chart 63: 30bps expansion in EBITDA margin over FY17-FY20 ....................................... 38
Chart 64: Net profit CAGR of 20.6% over FY17-20 ............................................................ 39
Chart 65: Net profit margin to improve ................................................................................ 39
Chart 66: Improving return ratios ahead ............................................................................. 39
Chart 67: Net working capital days ..................................................................................... 40
Chart 68: Operating cash flow to EBITDA .......................................................................... 40
Chart 69: Free cash flow to PAT ......................................................................................... 40
48
Godrej Agrovet, January 16, 2018 ICICI Securities
This report may be distributed in Singapore by ICICI Securities, Inc. (Singapore branch). Any recipients of this report in Singapore should contact ICICI Securities,
Inc. (Singapore branch) in respect of any matters arising from, or in connection with, this report. The contact details of ICICI Securities, Inc. (Singapore branch) are
as follows: Address: 10 Collyer Quay, #37-16 Ocean Financial Tower, Singapore - 049315, Tel: +65 6232 2451 and email: navneet_babbar@icicisecuritiesinc.com,
Rishi_agrawal@icicisecuritiesinc.com.
"In case of eligible investors based in Japan, charges for brokerage services on execution of transactions do not in substance constitute charge for research reports
and no charges are levied for providing research reports to such investors."
New I-Sec investment ratings (all ratings based on absolute return)
BUY: >15% return; ADD: 5% to 15% return; HOLD: Negative 5% to Positive 5% return; REDUCE: Negative 5% to Negative 15% return; SELL: < negative 15% return
ANALYST CERTIFICATION
We /I, Aniruddha Joshi, CA; Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report
accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to
the specific recommendation(s) or view(s) in this report. Analysts are not registered as research analysts by FINRA and are not associated persons of the ICICI
Securities Inc.
Terms & conditions and other disclosures:
ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of
financial products. ICICI Securities Limited is a SEBI registered Research Analyst with SEBI Registration Number – INH000000990. ICICI Securities is a wholly-owned
subsidiary of ICICI Bank which is India’s largest private sector bank and has its various subsidiaries engaged in businesses of housing finance, asset management, life
insurance, general insurance, venture capital fund management, etc. (“associates”), the details in respect of which are available on www.icicibank.com.
ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our
associates might have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research
Department. ICICI Securities generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or
derivatives of any companies that the analysts cover.
The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained
herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to
any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information
herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other
reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such
suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity
to this company, or in certain other circumstances.
This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy
or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or
solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers
may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes
investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities
discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment
objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The
recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange
rates or any other reason. ICICI Securities accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is
not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the
securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change
without notice.
ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject
company for any other assignment in the past twelve months.
ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from
the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage
services or other advisory service in a merger or specific transaction.
ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage
services from the companies mentioned in the report in the past twelve months.
ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its
analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research
report. Accordingly, neither ICICI Securities nor Research Analysts have any material conflict of interest at the time of publication of this report.
It is confirmed that Aniruddha Joshi, CA; Research Analysts of this report have not received any compensation from the companies mentioned in the report in the
preceding twelve months.
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
ICICI Securities or its subsidiaries collectively or Research Analysts do not own 1% or more of the equity securities of the Company mentioned in the report as of the
last day of the month preceding the publication of the research report.
Since associates of ICICI Securities are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various
companies including the subject company/companies mentioned in this report.
It is confirmed that Aniruddha Joshi, CA; Research Analysts do not serve as an officer, director or employee of the companies mentioned in the report.
ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report.
We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other
jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any
registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category
of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
This report has not been prepared by ICICI Securities, Inc. However, ICICI Securities, Inc. has reviewed the report and, in so far as it includes current or historical
information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed.
49